Kala Pharmaceuticals Announces Distribution of Series D Preferred Stock to Holders of its Common Stock
18.08.2022 - ARLINGTON, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) - Kala Pharmaceuticals, Inc. (NASDAQ:KALA) (“Kala” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies ... Seite 1